Clinical Trial Update: A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating QL1706 with chemotherapy induction for sequential immunotherapy consolidation in patients with limited-stage small cell lung…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• QL1706

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy | Phase 2 | Status: ACTIVE_NOT_RECRUITING